Patent · US Active

Solid pharmaceutical dosage form of ticagrelor

US8663661B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

ratiopharm GmbH · DE

Inventors

Sandra Brueck · Borgo San Lazzaro, DE
Dominique Meergans · Munich, DE

Key dates

Filing date	Dec 20, 2010
Grant date	Mar 4, 2014
Priority date	—
Expiry date	Dec 20, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a solid pharmaceutical dosage form comprising ticagrelor as pharmaceutically active ingredient, to certain particles of ticagrelor and to processes of preparing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.